Skip to main content
Clinical Trials/NCT04410705
NCT04410705
Unknown
N/A

Investigation the Effect of the Extracorporeal Shock Wave Therapy on Muscle Strength, Flexibility and Architectural Features in Lower Extremity Tendinopathies

Hacettepe University1 site in 1 country20 target enrollmentMay 11, 2020
ConditionsTendinopathy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tendinopathy
Sponsor
Hacettepe University
Enrollment
20
Locations
1
Primary Endpoint
muscle pannation angle
Last Updated
5 years ago

Overview

Brief Summary

The aim of the research is to investigate the effect of Ekstracorpereal shock wave treatment (ESWT) on muscle strength, flexibility and architecture of the lower extremity tendinopathies when applied using the frequencies specified in the literature with min and max frequency frequencies.

Our hypothesis as researchers is ESWT treatment has an effect on muscle strength, flexibility and muscle architecture.

Detailed Description

The study will conduct in the Physical Therapy and Radiology Department in a private hospital. The Clinical Research Ethics Committee of Gaziantep the univsersity approved ethical compliance of the study with the decision number GO 2018-01. The participants will inform about the study and their write consent will obtain. Demographic information including the name, age, height, body weight and occupation of the participants will obtain before the evaluation. All the measurements will perform before, soon after the 1st session and after the last session. Outcome measures will be muscle strength, muscle flexibility, muscle architectures parameters.

Registry
clinicaltrials.gov
Start Date
May 11, 2020
End Date
September 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aydan Niziplioğlu

MSc. physiotherapist

Hacettepe University

Eligibility Criteria

Inclusion Criteria

  • Lower extremity tendinopathy

Exclusion Criteria

  • Patients who failed to show up to any treatment and measurement sessions,
  • Patients who cannot tolerate treatment
  • having systemic inflammatory disease,
  • lower or upper motor lesion

Outcomes

Primary Outcomes

muscle pannation angle

Time Frame: Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment. Change of pannation angle in 3 weeks

'Logiq s7 Expert' US device including b-flow, semi-quantification and elastography, flow quantification, contrast imaging, b-steer and volume imaging device and with 11 L-D linear volume convex and linear probe will use for the measurements. During the evaluation, the muscles will place in the most relaxed position and no contraction will request. Pennation angle will measure as the angle between muscle fibre and the deep fascia of the muscle

muscle thickness

Time Frame: Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment.Change of thickness in 3 weeks

'Logiq s7 Expert' US device including b-flow, semi-quantification and elastography, flow quantification, contrast imaging, b-steer and volume imaging device and with 11 L-D linear volume convex and linear probe will use for the measurements. During the evaluation, the muscles will place in the most relaxed position and no contraction will reques thickness will measure in transversal as the distance between the superficial and the deep fascia at distance

muscle fiber length

Time Frame: Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment.Change of fiber length in 3 weeks

'Logiq s7 Expert' US device including b-flow, semi-quantification and elastography, flow quantification, contrast imaging, b-steer and volume imaging device and with 11 L-D linear volume convex and linear probe will use for the measurements. During the evaluation, the muscles will place in the most relaxed position and no contraction will request. Fiber length will measure as the length of the fascicular path between the superficial and deep aponeurosis. For the measuring of the fiber length , the most clearly measure areas will be taken into consideration. If the fascicle extended off the image, the missing portion will estimate via linear extrapolation of the fascicle and aponeurosis

Secondary Outcomes

  • Quadriceps muscle flexibility(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment.Change of flexibility in 3 weeks)
  • hamstring muscle strength(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment. Change of strength in 3 weeks)
  • gastrokinemius muscle strength(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment.Change of strength in 3 weeks)
  • Gastrocinemius muscle flexibility(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment..Change of flexibility in 3 weeks)
  • Quadriceps muscle strength(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment..Change of strength in 3 weeks)
  • Hamstring muscle flexibility(Measurements will perform prior to ESWT,immidiately after the first ESWT and last ESWT treatment..Change of flexibility in 3 weeks)

Study Sites (1)

Loading locations...

Similar Trials